Cereno Scientific on Jones Hosts: Charting The PAH-th Forward (Pulmonary Panel Discussion)

On June 24, our CMO and Head of R&D, Rahul Agrawal, was joined by Martin Voss, the CEO of Tiakis Biotech - another company developing treatments for pulmonary arterial hypertension and Dr. Bhuvin Buddhdev, MD, FCCP, Director, Pulmonary Hypertension Program, Co-director, Interstitial Lung Disease Program, St. Joseph’s Hospital and Medical Center, Arizona - in a panel discussion centering on new treatment paradigms in PAH. The discussion was hosted by Jones Trading, a leading US-based investment bank.

Watch here >